Skip to main content
Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · IEX Real-Time Price · USD
6.82
+0.10 (1.49%)
Apr 19, 2024, 4:00 PM EDT - Market closed

Nuvectis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022
Market Capitalization
121145110
Market Cap Growth
-31.58%-
Enterprise Value
9912590
PE Ratio
-6.49-6.49-5.75
PB Ratio
9.7211.847.72
P/FCF Ratio
-9.06-9.06-8.10
P/OCF Ratio
-9.06-9.06-8.10
EV/EBITDA Ratio
-5.63-5.63-4.71
EV/EBIT Ratio
-5.63-5.63-4.71
EV/FCF Ratio
-7.86-7.86-6.62
Quick Ratio
2.742.743.23
Current Ratio
2.752.753.30
Return on Equity (ROE)
-144.80%-144.80%-125.90%
Return on Assets (ROA)
-107.80%-107.80%-99.00%
Return on Capital (ROIC)
-187.66%-187.66%-135.27%
Earnings Yield
-18.77%-15.40%-17.38%
FCF Yield
-13.45%-11.04%-12.35%
Buyback Yield / Dilution
-22.90%-22.90%-196.55%
Total Shareholder Return
-22.90%-22.90%-196.55%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).